These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 24774118

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Reducing the dose of diuretics for heart failure patients: how low can it go?
    Oshima K, Kohsaka S, Koide K, Yoshikawa T.
    Cardiology; 2009; 114(2):89. PubMed ID: 19420935
    [No Abstract] [Full Text] [Related]

  • 23. Acute decompensated heart failure.
    Smithline HA.
    CMAJ; 2007 Jul 17; 177(2):175; author reply 175-6. PubMed ID: 17638957
    [No Abstract] [Full Text] [Related]

  • 24. Dose-dependent association between use of loop diuretics and mortality in advanced systolic heart failure.
    Chuen MJ, MacFadyen RJ.
    Am J Cardiol; 2006 Nov 15; 98(10):1416-7. PubMed ID: 17134642
    [No Abstract] [Full Text] [Related]

  • 25. Intravenous salt supplementation with low-dose furosemide for treatment of acute decompensated heart failure.
    Okuhara Y, Hirotani S, Naito Y, Nakabo A, Iwasaku T, Eguchi A, Morisawa D, Ando T, Sawada H, Manabe E, Masuyama T.
    J Card Fail; 2014 May 15; 20(5):295-301. PubMed ID: 24462960
    [Abstract] [Full Text] [Related]

  • 26. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment.
    Testani JM, Brisco MA, Kociol RD, Jacoby D, Bellumkonda L, Parikh CR, Coca SG, Tang WH.
    Am J Med; 2015 Jul 15; 128(7):776-83.e4. PubMed ID: 25595470
    [Abstract] [Full Text] [Related]

  • 27. Prognostic implications of diuretic dose in chronic heart failure.
    Martins J, Lourenço P, Araújo JP, Mascarenhas J, Lopes R, Azevedo A, Bettencourt P.
    J Cardiovasc Pharmacol Ther; 2011 Jun 15; 16(2):185-91. PubMed ID: 21335479
    [Abstract] [Full Text] [Related]

  • 28. Palliative use of furosemide in continuous subcutaneous infusion in a renal transplant patient with heart failure.
    Picazo Sánchez M, Castillo Lorenzo MN, Cuxart Pérez M, Sans Lorman R.
    Nefrologia (Engl Ed); 2018 Jun 15; 38(4):438-439. PubMed ID: 29275931
    [No Abstract] [Full Text] [Related]

  • 29. Intermittent levosimendan infusions in advanced heart failure: favourable effects on left ventricular function, neurohormonal balance, and one-year survival.
    Malfatto G, Della Rosa F, Villani A, Rella V, Branzi G, Facchini M, Parati G.
    J Cardiovasc Pharmacol; 2012 Nov 15; 60(5):450-5. PubMed ID: 22932705
    [Abstract] [Full Text] [Related]

  • 30. Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion.
    Dormans TP, van Meyel JJ, Gerlag PG, Tan Y, Russel FG, Smits P.
    J Am Coll Cardiol; 1996 Aug 15; 28(2):376-82. PubMed ID: 8800113
    [Abstract] [Full Text] [Related]

  • 31. Acute decompensated heart failure.
    Nemeth J.
    CMAJ; 2007 Jul 17; 177(2):175; author reply 175-6. PubMed ID: 17638958
    [No Abstract] [Full Text] [Related]

  • 32. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA, Das S, O'Keefe JH.
    Heart Fail Clin; 2006 Jan 17; 2(1):81-8. PubMed ID: 17386879
    [No Abstract] [Full Text] [Related]

  • 33. Intravenous Furosemide for Acute Decompensated Congestive Heart Failure: What Is the Evidence?
    Owen DR, MacAllister R, Sofat R.
    Clin Pharmacol Ther; 2015 Aug 17; 98(2):119-21. PubMed ID: 25786394
    [Abstract] [Full Text] [Related]

  • 34. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M, Houpe D, Cohen-Solal A, Béguin M, Levy F, Tribouilloy C.
    Int J Cardiol; 2007 Jun 12; 118(3):363-9. PubMed ID: 17049391
    [Abstract] [Full Text] [Related]

  • 35. Impact of Compound Hypertonic Saline Solution on Decompensated Heart Failure.
    Wan Y, Li L, Niu H, Ma X, Yang J, Yuan C, Mu G, Zhang J.
    Int Heart J; 2017 Aug 03; 58(4):601-607. PubMed ID: 28701670
    [Abstract] [Full Text] [Related]

  • 36. The prognostic implications of outpatient diuretic dose in heart failure.
    Harjai KJ, Dinshaw HK, Nunez E, Shah M, Thompson H, Turgut T, Ventura HO.
    Int J Cardiol; 1999 Dec 01; 71(3):219-25. PubMed ID: 10636527
    [Abstract] [Full Text] [Related]

  • 37. Diuretic effects of furosemide infusion versus bolus injection in congestive heart failure.
    Pivac N, Rumboldt Z, Sardelić S, Bagatin J, Polić S, Ljutić D, Naranca M, Capkun V.
    Int J Clin Pharmacol Res; 1998 Dec 01; 18(3):121-8. PubMed ID: 9825268
    [Abstract] [Full Text] [Related]

  • 38. A diuretic protocol increases volume removal and reduces readmissions among hospitalized patients with acute decompensated heart failure.
    Barsuk JH, Gordon RA, Cohen ER, Cotts WG, Malkenson D, Yancy CW, Williams MV.
    Congest Heart Fail; 2013 Dec 01; 19(2):53-60. PubMed ID: 23336425
    [Abstract] [Full Text] [Related]

  • 39. Acutely decompensated systolic heart failure: effects of frequent doses of furosemide vs a single dose plus carvedilol on clinical status, neurohormonal activation and ventricular arrhythmias.
    Lobo-Vielma L, Colmenarez-Mendoza H, Donis JH, Sanchez F, Perez A, Villarroel V, Dávila DF.
    Int J Cardiol; 2010 Oct 08; 144(2):302-3. PubMed ID: 19329199
    [Abstract] [Full Text] [Related]

  • 40. Subcutaneous furosemide for the treatment of heart failure: a state-of-the art review.
    Afari ME, Aoun J, Khare S, Tsao L.
    Heart Fail Rev; 2019 May 08; 24(3):309-313. PubMed ID: 30617666
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.